TP53 and neoplasm: Alternative reading frame protein (ARF; known as p14ARF in humans or p19ARF in mice) is involved in the p53 tumor-suppressor pathway (1) in which ARF inhibits the ubiquitin–protein ligase Mdm2 (or HDM2), and leads to stabilization and elevated levels of p53 (2–5).